Хайлтын үр дүнгүүд - Natarajan Muthusamy
- 43-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
Human T-Cell Lymphotropic Virus Type 1 p12<sup>I</sup>Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells -н Wei Ding, Björn Albrecht, Robert E. Kelley, Natarajan Muthusamy, Seung-Jae Kim, Ruth A. Altschuld, Michael D. Lairmore
Хэвлэсэн 2002Artigo -
5
A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders -н John M. Timmerman, John C. Byrd, David Andorsky, Reiko Yamada, Janet Kramer, Natarajan Muthusamy, Naomi Hunder, John M. Pagel
Хэвлэсэн 2012Artigo -
6
Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas -н Pankaj Gupta, David M. Goldenberg, Edmund A. Rossi, Thomas M. Cardillo, John C. Byrd, Natarajan Muthusamy, Richard R. Furman, Chien‐Hsing Chang
Хэвлэсэн 2012Artigo -
7
Comparative Assessment of Clinically Utilized CD20-Directed Antibodies in Chronic Lymphocytic Leukemia Cells Reveals Divergent NK Cell, Monocyte, and Macrophage Properties -н Sarwish Rafiq, Jonathan P. Butchar, Carolyn Cheney, Xiaokui Mo, Rossana Trotta, Michael A. Caligiuri, David Jarjoura, Susheela Tridandapani, Natarajan Muthusamy, John C. Byrd
Хэвлэсэн 2013Artigo -
8
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia -н Amy J. Johnson, David Lucas, Natarajan Muthusamy, Lisa L. Smith, Ryan B. Edwards, Michael De Lay, Carlo M. Croce, Michael R. Grever, John C. Byrd
Хэвлэсэн 2006Artigo -
9
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia -н Emily M. McWilliams, Jennifer M. Mele, Carolyn Cheney, Elizabeth A. Timmerman, Faraz Fiazuddin, Ethan Strattan, Xiaokui Mo, John C. Byrd, Natarajan Muthusamy, Farrukh T. Awan
Хэвлэсэн 2016Artigo -
10
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma -н Qing Liu, Xiaobin Zhao, Frank Frissora, Yihui Ma, Ramasamy Santhanam, David Jarjoura, Amy Lehman, Danilo Perrotti, Ching‐Shih Chen, James T. Dalton, Natarajan Muthusamy, John C. Byrd
Хэвлэсэн 2007Artigo -
11
Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis -н Wei Guo, Ruchika Srinivasan, Carmen Z. Cantemir-Stone, Sudarshana M. Sharma, Ramasamy Santhanam, Michael Weinstein, Natarajan Muthusamy, Albert K. Man, Robert G. Oshima, Gustavo Leone, Michael C. Ostrowski
Хэвлэсэн 2009Artigo -
12
Chronic Lymphocytic Leukemia–Derived IL-10 Suppresses Antitumor Immunity -н Sara S. Alhakeem, Mary K. McKenna, Karine Z. Oben, Sunil K. Noothi, Jacqueline R. Rivas, Gerhard C. Hildebrandt, Roger A. Fleischman, Vivek M. Rangnekar, Natarajan Muthusamy, Subbarao Bondada
Хэвлэсэн 2018Artigo -
13
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression -н Shuai Dong, Bonnie K. Harrington, Eileen Hu, J.T. Greene, Amy M. Lehman, Minh Tran, Ronni Wasmuth, Meixiao Long, Natarajan Muthusamy, Jennifer R. Brown, Amy J. Johnson, John C. Byrd
Хэвлэсэн 2018Artigo -
14
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia -н Sarah E.M. Herman, Rosa Lapalombella, Amber Gordon, Asha Ramanunni, Kristie A. Blum, Jeffrey A. Jones, Xiaoli Zhang, Brian J. Lannutti, Kamal D. Puri, Natarajan Muthusamy, John C. Byrd, Amy J. Johnson
Хэвлэсэн 2011Artigo -
15
Ibrutinib antagonizes rituximab-dependent NK cell–mediated cytotoxicity -н Holbrook E. Kohrt, Idit Sagiv-Barfi, Sarwish Rafiq, Sarah E.M. Herman, Jonathan P. Butchar, Carolyn Cheney, Xiaoli Zhang, Joseph J. Buggy, Natarajan Muthusamy, Ronald Levy, Amy J. Johnson, John C. Byrd
Хэвлэсэн 2014Carta -
16
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing -н Jason A. Dubovsky, Danielle L. Chappell, Bonnie K. Harrington, Kitty Agrawal, Leslie A. Andritsos, Joseph M. Flynn, Jeffrey A. Jones, Michael E. Paulaitis, Brad Bolon, Amy J. Johnson, John C. Byrd, Natarajan Muthusamy
Хэвлэсэн 2013Artigo -
17
<i>Retracted:</i> Antitumor effects of OSU‐2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma -н Hany A. Omar, Chih-Chien Chou, Lisa D. Berman-Booty, Yihui Ma, Jui‐Hsiang Hung, Dasheng Wang, Takayuki Kogure, Tushar Patel, Luigi Terracciano, Natarajan Muthusamy, John C. Byrd, Samuel K. Kulp, Ching‐Shih Chen
Хэвлэсэн 2011Artigo -
18
Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia -н Jacqueline R. Rivas, Y Liu, Sara S. Alhakeem, Joseph M. Eckenrode, Francesc Martí, James P. Collard, Yanbin Zhang, Khaled A. Shaaban, Natarajan Muthusamy, Gerhard Hildebrandt, Roger A. Fleischman, L Chen, Jon S. Thorson, Markos Leggas, Subbarao Bondada
Хэвлэсэн 2021Artigo -
19
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical -н Zhao Xiaobin, Rosa Lapalombella, Trupti Joshi, Carolyn Cheney, Aruna Gowda, Martha Hayden-Ledbetter, Peter Baum, Thomas S. Lin, David Jarjoura, Amy Lehman, Donna Kussewitt, Robert J. Lee, Michael A. Caligiuri, Susheela Tridandapani, Natarajan Muthusamy, John C. Byrd
Хэвлэсэн 2007Artigo -
20
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leu... -н Aruna Gowda, Julie M. Roda, Syed-Rehan A. Hussain, Asha Ramanunni, Trupti Joshi, S. Schmidt, Xiaoli Zhang, Amy Lehman, David Jarjoura, William E. Carson, Wayne Kindsvogel, Carolyn Cheney, Michael A. Caligiuri, Susheela Tridandapani, Natarajan Muthusamy, John C. Byrd
Хэвлэсэн 2008Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Cancer research
Immunology
Biology
Leukemia
Chronic lymphocytic leukemia
Medicine
Biochemistry
Genetics
Chemistry
Immune system
Antibody
Gene
In vitro
Receptor
Cell biology
Ibrutinib
Internal medicine
Monoclonal antibody
Pharmacology
CD20
Cytotoxicity
Lymphoma
Molecular biology
Antibody-dependent cell-mediated cytotoxicity
Apoptosis
Bruton's tyrosine kinase
Rituximab
Tyrosine kinase
Cell
Cytokine